# Articles

### Designing for time-to-event endpoints

These vignettes provide an introduction to designing group sequential
trials with time-to-event endpoints using gsDesign.

- [Overview of survival endpoint
  design](https://keaven.github.io/gsDesign/articles/SurvivalOverview.md):
- [Integer sample size and event
  counts](https://keaven.github.io/gsDesign/articles/toInteger.md):
- [Basic time-to-event group sequential design using
  gsSurv](https://keaven.github.io/gsDesign/articles/gsSurvBasicExamples.md):
- [Futility and harm bounds for overall survival
  monitoring](https://keaven.github.io/gsDesign/articles/HarmBound.md):
- [Selective bound testing at interim
  analyses](https://keaven.github.io/gsDesign/articles/SelectiveBoundTesting.md):
- [A cure model calendar-based
  design](https://keaven.github.io/gsDesign/articles/PoissonMixtureModel.md):

### Other

Other vignettes.

- [A gentle introduction to group sequential
  design](https://keaven.github.io/gsDesign/articles/GentleIntroductionToGSD.md):
- [gsDesign package
  overview](https://keaven.github.io/gsDesign/articles/gsDesignPackageOverview.md):
- [Spending function
  overview](https://keaven.github.io/gsDesign/articles/SpendingFunctionOverview.md):
- [Conditional power and conditional
  error](https://keaven.github.io/gsDesign/articles/ConditionalPowerPlot.md):
- [Conditional error spending
  functions](https://keaven.github.io/gsDesign/articles/ConditionalErrorSpending.md):
- [Two-sample normal sample
  size](https://keaven.github.io/gsDesign/articles/nNormal.md):
- [Multiplicity
  graphs](https://keaven.github.io/gsDesign/articles/hGraph.md):
- [Graphical testing for group sequential
  design](https://keaven.github.io/gsDesign/articles/GraphicalMultiplicity.md):
- [Vaccine efficacy trial
  design](https://keaven.github.io/gsDesign/articles/VaccineEfficacy.md):
- [Binomial two arm trial design and
  analysis](https://keaven.github.io/gsDesign/articles/binomialTwoSample.md):
- [Binomial
  SPRT](https://keaven.github.io/gsDesign/articles/binomialSPRTExample.md):
